CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

0.63% 2.34% 3.79% 6.21%
Piotroski F-Score
7 7 5 6
ROA
0.18% 0.70% 1.15% 1.91%
ROIC
2.41% 2.25% 2.89% 4.07%
Return on Tangible Assets
(17.07%) (197.54%) 202.49% 331.98%
Average Days of Receivables
40.62 36.11 36.68 35.45
Free Cash Flow per Share
4.96 6.16 5.81 9.19
Free Cash Flow
6,293.00 7,807.00 7,394.00 11,758.00
Capital Expenditures
(2,816.00) (2,832.00) (2,938.00) (3,022.00)
Other line items
Cash ROIC
4.19% 5.19% 4.85% 7.57%
Accounts Receivable Turnover
9.85 10.55 10.12 10.25
Accounts Payable Turnover
12.99 13.19 13.48 13.39
Inventory Turnover
11.87 11.84 12.83 13.14
Average Days of Payables
29.83 29.11 27.38 27.19
Days of Inventory on Hand
31.84 31.76 28.76 27.92
Tax Rate
(0.85) (0.19) (0.16) (0.16)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.14% 0.13% 0.17% 0.17%
Interest Coverage
1.59 1.49 1.92 2.67
Operating CF/Net income
19.42 6.02 3.52 3.02
Depreciation/Fixed assets
0.80 0.79 0.79 0.78
Capex/Depreciation
(0.27) (0.27) (0.29) (0.29)
Revenue per Share
310.55 317.34 320.43 324.54
Operating CF per Share
7.18 8.40 8.12 11.56
Capex per Share
(2.22) (2.24) (2.31) (2.36)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates